ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization
Device DX - Diagnostics incl. all products and services
General payments
$100,466
Research payments
$7,730,498
Through program year 2020, $100,466 in general payments and $7,730,498 in research payments were reported against ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $50,691 | 21 |
| 2020 | Research | $4,133,135 | 257 |
| 2019 | General | $49,775 | 48 |
| 2019 | Research | $3,597,363 | 185 |
Breakdown
The top 5 of 13 recipients; each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
69 general · 442 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.